Melissa Tosca
Director of Finance/CFO at KIORA PHARMACEUTICALS, INC.
Net worth: 1 962 $ as of 30/05/2024
Profile
Melissa Tosca is currently the Executive Vice President-Finance at Kiora Pharmaceuticals, Inc. She previously worked at Neomorph, Inc. as the Treasurer & Executive Director-Finance.
Ms. Tosca completed her undergraduate degree at the University of Arizona.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/06/2024 | 3,979 ( 0.02% ) | 1 962 $ | 30/05/2024 |
Melissa Tosca active positions
| Companies | Position | Start |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Former positions of Melissa Tosca
| Companies | Position | End |
|---|---|---|
Neomorph, Inc.
 Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Director of Finance/CFO | - |
Training of Melissa Tosca
| University of Arizona | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Neomorph, Inc.
Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Melissa Tosca
